The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The stock hit a fresh record high of Rs 910, up 5% on the BSE in early morning trade.
The stock dropped 8% after rising over 5% in intra-day trade
IT majors were the top losers in noon trade while ITC was among the top gainers
The stock it a fresh 52-week high of Rs 149, rallied 15% in past three trading sessions from Rs 130 on August 22.
The stock hit a record high of Rs 539, rallied 63% from Rs 330 on August 8, post Q1FY17 results.
Market participants are keenly awaiting signals on key policy rates from US Federal Reserve Chair Janet Yellen
The stock was down 6.4% to Rs 1,067, as compared to 0.27% rise in the S&P BSE Sensex at 10:16 am.
The stock moved higher to its fresh lifetime high of Rs 703, up 7% on the National Stock Exchange.
The stock rallied 12% to Rs 135, also its 52-week high on the BSE in early morning trade.
Ramco Ind, Sequent Scientific, BF Investment, J B Chem, Kalyani Investment and Tata Investment rallied over 10% each on Wednesday.
Post listing, the stock underperformed the market by falling nearly 9% as compared to 1% rise in the Sensex.
FMCG majors were among the top losers along with select Tata group shares
Sequent Scientific, Torrent Pharma, Hikal, Ipca Lab and Aurobindo Pharma were up between 5%-20% on the BSE.
The stock nearly 5% to Rs 568 after the company said that its board will meet on August 29 to consider bonus issue proposal.
The stock rallied 6% to Rs 245 after the company reported 50% YoY jump in net profit at Rs 80 crore for Q1FY17.
The stock surged 12% to Rs 544 on the BSE on back of heavy volumes.
The stock rallied 6% to Rs 778 after the company reported 24% YoY jump in consolidated net profit at Rs 585 crore in Q1FY17.
The stock is currently trading at Rs 59.30, its fresh 52-week low, falling 42% in past three days from Rs 102.85 on BSE.
Index heavyweight Infosys and Aurobindo Pharma were among the top Nifty gainers in early trades
The stock dipped 6% to Rs 1,144 on the BSE in intra-day trade.